Lipitab Gold 20 Capsule is a combination medication containing Aspirin (75 mg), Atorvastatin (20 mg), and Clopidogrel (75 mg), formulated to manage cardiovascular risk factors in patients with established atherosclerotic cardiovascular disease or those at high risk of such conditions. Aspirin acts as an antiplatelet agent by irreversibly inhibiting cyclooxygenase, thereby reducing thromboxane A2 production and preventing platelet aggregation. Atorvastatin, a potent HMG-CoA reductase inhibitor, effectively lowers low-density lipoprotein cholesterol (LDL-C) and triglycerides while modestly increasing high-density lipoprotein cholesterol (HDL-C), contributing to plaque stabilization and reduction of cardiovascular events. Clopidogrel, a thienopyridine antiplatelet agent, inhibits the ADP-mediated activation of the glycoprotein IIb/IIIa complex, further preventing platelet aggregation. The synergistic effect of these three agents provides comprehensive cardiovascular protection by reducing the risk of myocardial infarction, stroke, and other thrombotic events in patients with coronary artery disease, peripheral arterial disease, or cerebrovascular disease. Lipitab Gold 20 Capsule should be used under medical supervision, considering potential contraindications such as bleeding disorders, hypersensitivity, and concomitant use of other anticoagulants or antiplatelet drugs. Regular monitoring of lipid profiles, liver function, and bleeding parameters is recommended during therapy.